Khosla Ventures

Khosla Ventures, founded in 2004 and headquartered in Menlo Park, California, is a venture capital firm that provides strategic advice, capital, and support to bold entrepreneurs across various sectors. The firm focuses on early-stage investments in areas such as artificial intelligence, climate technology, sustainability, enterprise solutions, consumer products, fintech, digital health, medical technology, and therapeutics. Khosla Ventures is particularly interested in innovative solutions that address significant socio-economic challenges and enhance productivity, especially for low-income populations and small businesses in emerging markets. The firm embraces experimentation and is open to investing in unconventional and high-risk ventures, often acting as the sole investor in groundbreaking projects. With a commitment to fostering impactful entrepreneurship, Khosla Ventures seeks to create value through technological advancements and creative business models, with a special emphasis on markets in South Asia.

Bruce Armstrong

Partner

Alex Bentley

Partner and Investor

Blignaut, Ryno

Operating Partner

Alice Brooks

Principal

Peter Buckland

General Partner and COO

Byun, Brian

Venture Partner

Catherine Casuga

Operating Partner

Jon Chu

Partner and Investor

Ece Erdagoz

Principal

Bryan Gartner

Partner

Kanu Gulati

Partner

Judy Huang

Operating Partner

Khosla, Vinod

Managing Director

Kelly Kinnard

Operating Partner

Alexander Morgan

Partner

Arash Rebek JD

Partner, Capital Formation

Jessy Rivest

Partner and Investor

Scanlan, Leah

Operating Partner

Nikita Shamgunov

Partner

Sven Strohband Ph.D

Managing Director

Rajesh Swaminathan

Partner

David Weiden

Managing Director

Ece Wyrick

Principal and Investor

Adam Coates Ph.D

Operating Partner

Kanupriya Gulati Ph.D

Partner and Investor

1061 past transactions

Nomba

Series B in 2023
Nomba is a fintech company that offers financial software solutions. They provide fintech services such as bussiness saving, joint bussiness saving, card payments, POS terminals, management, and banking tools solutions for bussiness.

Replit

Series B in 2023
Replit is a browser-based integrated development environment (IDE) built for cross-platform collaborative coding. With assistance from more than 50 programming languages, it can be utilized to construct apps and websites via a browser on any working system or system (together with cell), with the added skill to share initiatives and create communal workspaces, and grant entry to containers for executing code. The company was founded in 2016 and is headquartered in San Francisco, California.

Kind Humanoid

Pre Seed Round in 2023
Kind Humanoid delivers intelligent robots and provides additional labor to build a better tomorrow.

Mojo Vision

Series C in 2023
Mojo Vision is focused on developing and commercializing high-performance micro-LED display technology for consumer, enterprise, and government applications. The company combines breakthrough technology, leading display and semiconductor expertise, and an advanced 300mm manufacturing process to deliver on the promise of micro-LED displays. Mojo’s proprietary quantum-dot technology brings full-color capability to its display platform and meets the superior performance demands for all form factors. Mojo Vision developed the world’s smallest, densest dynamic display for the first AR smart contact lens and is now applying this innovation and expertise to lead the disruption of the $160 billion display industry. Mojo Vision was founded in 2015 and headquartered in Saratoga, California.

Regie.ai

Series A in 2023
Regie.ai develops an AI-powered sales engagement platform that automates outbound prospecting and enhances workflow efficiency. The company's platform, RegieOne, integrates sales engagement, parallel dialing, enrichment, and intent data, providing operations teams with a centralized view of their processes

Light Field Lab

Series B in 2023
Light Field Lab is a breakthrough technology startup that builds an innovative holographic ecosystem. It re-creates what optical physics calls a real image for off-screen projected objects by generating a massive number of viewing angles that correctly change with the point of view and location just like in the real world. They enable entirely new business opportunities across consumer and enterprise markets. The company was founded in 2017 by Jon Karafin, Brendan Bevensee, and Ed Ibe, with the single mission to enable a holographic future by building upon the founders’ collective expertise of light field technology innovation. Based in San Jose, CA, Light Field Lab is backed by top-tier venture firms including Khosla Ventures.

Moonhub

Seed Round in 2023
Moonhub's mission is to create economic opportunity for every person on the planet. They built the world's first AI Recruiter to find and hire the perfect person for every single job opening.

IgGenix

Series B in 2023
IgGenix is a biotechnology company, directly address food and other severe allergies by re-engineering key antibodies involved in the allergic cascade. IgGenix isolates and transforms allergen-specific IgE antibodies into IgG antibodies that are designed to alleviate and possibly prevent the allergic cascade.

Equii

Seed Round in 2022
Equii is a food technology company that discovers highly nutritious sources of microbial proteins that are used to ferment grains and produce high-protein grain flours. Founded in 2021 by Monica Bhatia, Equii is based in San Ramon, California.

Mainspring Energy

Series E in 2022
Mainspring Energy is engineering advanced technology by developing a prototype of a linear generator that converts fuel to electricity. Mainspring was founded in 2010 by three Stanford engineers- Shannon Miller, Adam Simpson, and Matt Svrcek. Today Mainspring brings together a diverse, talented team of individuals who share the vision to address the growing threat of climate change and the need for affordable electricity for all.

Proclaim

Series B in 2022
Proclaim is a developer of a oral care platform designed to prevent oral diseases.

AliveCor

Series F in 2022
AliveCor, Inc. is a technology company that develops digital medical-grade electrocardiograms, enabling users to monitor their heart health through mobile devices. Its flagship product, KardiaMobile, provides instant detection of common heart arrhythmias and allows users to track blood pressure and weight, as well as store recorded EKGs. The company also offers KardiaMobile 6L, a six-lead EKG device that allows patients to share detailed readings with their healthcare providers. Additionally, AliveCor has introduced KardiaCare, a digital health subscription service that facilitates the management of heart health at home. Founded in 2010 and headquartered in Mountain View, California, AliveCor is recognized for its pioneering efforts in using machine learning techniques to enhance cardiac care and improve early detection of conditions such as atrial fibrillation.

Prellis Biologics

Series C in 2022
Prellis Biologics is building human tissues for drug development, and ultimately, developing human organs for transplantation. Bioprinting vascularized human tissue and organs will revolutionize healthcare. Prellis Biologics'​ technology leverages massive gains in print speed and resolution to break the microvasculature barrier. The company was founded in 2016 and is based in San Francisco, California.

Genecis

Series A in 2022
Genecis is an early-stage organic waste processing startup that uses biotechnology to convert waste into biodegradable plastics and other high-value materials. It converts organic waste into PHA (Polyhydroxyalkanoate), a biodegradable, compostable, and non-toxic polymer that can be tuned to replace a wide variety of traditional plastics. PHA can be used for single-use plastics, clothing and textiles, automotive interiors, medical tools and products, and food contact applications.

Swadesh

Pre Seed Round in 2022
Swadesh is a digital banking experience built from the ground up, specifically for the Indian diaspora. They make it delightful for its customers to invest, remit and manage their money in India from abroad.

Traba

Series A in 2022
Traba is building a world where the global supply chain operates at peak efficiency. We connect industrial businesses with reliable workers to fill open shifts and empower both businesses and workers to reach their full productivity and potential.

Tabnine

Venture Round in 2022
Tabnine is an AI coding assistant that helps development teams of every size use AI to accelerate and simplify the software development process without sacrificing privacy & security

Relation Therapeutics

Seed Round in 2022
Relation Therapeutics is a biotechnology company that focuses on humanizing drug discovery and development. It leverages human genetics and clinical omics data and utilizes patient-derived tissue samples with functional genomics interventional experiments to identify, validate, and prosecute therapeutic programs.

CHARM Therapeutics

Series A in 2022
CHARM Therapeutics delivers transformational medicines through 3D deep learning and cutting-edge drug discovery technologies. It delivers transformational medicines through 3D deep learning and cutting-edge drug discovery technologies to help doctors in treating undruggable disease targets.

TeraWatt Technology

Series B in 2022
TeraWatt Technology is a manufacturing company that produces lithium-ion batteries.

Anagenex

Series A in 2022
Anagenex is a seed stage biotechnology company building a novel platform for drug discovery focusing on difficult targets.

Nitricity

Venture Round in 2022
Nitricity is an energy company that creates renewable nitrogen fertilizer production with zero carbon emissions.

Ivy Homes

Seed Round in 2022
Ivy Homes provides instant offers and an easy and safe way to sell and buy homes.

Ultima Genomics

Venture Round in 2022
Ultima Genomics is unleashing the power of genomics at scale. Ultima Genomics drives the scale of genomic information to enable unprecedented advances in biology and improvements in human health. The company was founded in 2016 and is based in Newark, California.

Oobli

Series B in 2022
Joywell Foods is developing the first healthy, protein sweeteners. Derived from exotic plants, protein sweeteners are rare compounds that provide an amazing taste without the calories. These proteins, produced through fermentation, have no glycemic impact and do not affect the gut microbiome. The company has received regulatory approvals, including FDA "no questions" letters and GRAS status for multiple proteins

Finnt

Seed Round in 2022
Finnt uses AI to streamline corporate finance operations

Nomagic

Series A in 2022
Nomagic provides smart pick and place robotic solutions for order fulfillment. Their solutions bring efficiency, flexibility and reliability to e-commerce warehouses. They automate tedious tasks while reducing the cost of fulfillment and allow warehouses to face shortage of labor and scale easily to 24/7 operations. Nomagic's first robots are on packing lines at Cdiscount, the #1 French eCommerce platform.

Mainspring Energy

Series E in 2022
Mainspring Energy is engineering advanced technology by developing a prototype of a linear generator that converts fuel to electricity. Mainspring was founded in 2010 by three Stanford engineers- Shannon Miller, Adam Simpson, and Matt Svrcek. Today Mainspring brings together a diverse, talented team of individuals who share the vision to address the growing threat of climate change and the need for affordable electricity for all.

Imply

Series D in 2022
Imply, founded by the original creators of Apache Druid, provides a complete real-time analytics platform based on Apache Druid. Imply is a multi-cloud data platform designed to deliver real-time ingestion and visualizations for event-driven and streaming data flows. Apache Druid, an open-source database created by Imply's founders, enables next-generation real-time analytics solutions. Druid is widely adopted for analyzing user activity data, digital media logs, network flows, server metrics, application logs, and many other types of event-driven, streaming data. Druid is used in production by the world's largest and most innovative companies. Imply is originating and leading a new category of data analytics focused on analytics-in-motion. With analytics-in-motion, organizations can move away from analytics solutions that are static, difficult to scale, delayed, and expensive and towards analytics solutions that are interactive, highly scalable, real-time, and cost-effective. Leading organizations worldwide leverage Imply as the engine for analytics-powered applications that they build, and/or as a complete solution to directly solve internal BI and operational analytics use cases. Imply has operations in North America, Europe, and Asia Pacific and is backed by A16Z, Bessemer Venture Partners, Tiger Global Management, Khosla Ventures, and Geodesic Capital.

Mirvie

Series B in 2022
Mirvie is a biotech company that creates precise, actionable, and non-invasive tests for maternal-fetal health. The company delivers insights to moms and families to make pregnancy safe. It was founded in 2018 by Maneesh Jain and is headquartered in South San Francisco, California, United States.

Bubbles

Seed Round in 2022
Bubbles is a collaboration tool that lets's tag anything on screen and invite teammates to discuss in-context. Get excited by organic growth and viral loops, and less so by paid advertising. Are active on one or more social platforms like Medium, Twitter, Product Hunt, etc. It was founded in 2018 and is based inSan Francisco, California.

Adyton PBC

Venture Round in 2022
Experience the brilliance of getting the basics right with AOK. The Adyton Operations Kit is secure mobile software for mission-critical work. AOK is built for the warfighter in mind, allowing secure access on-the-go, while also generating data for the enterprise.

VitroLabs

Series A in 2022
VitroLabs is a startup working on the cutting edge of 3D tissue engineering using stem cell-based technologies. The company develops a fully scalable tissue engineering platform combining the latest breakthroughs in stem cell research and biomaterials. It manufactures real leather without the need to raise and slaughter animals using breakthroughs in stem cell research and tissue engineering. VitroLabs was founded on 2016 and is based in San Jose, California.

Primer

Series A in 2022
At Primer Microschools, students learn at their own pace, pursue their passions, and get the support they deserve. A school designed for tomorrow's leaders, enrolling today.

Enso

Seed Round in 2022
Enso is a creative impact agency based in Santa Monica, California, founded in 2012. The agency focuses on leveraging strategic, creative, and community-building skills to improve both the planet and the lives of individuals. Enso aims to disrupt the status quo by developing innovative ideas that can scale through shared missions, fostering collaboration among brands, organizations, and communities around common goals. Additionally, Enso facilitates the rapid creation of software, enabling business leaders, analysts, data scientists, and developers to design workflows collaboratively and enhance communication effectively.

Loop

Series B in 2022
By using data, technology, and high quality medical expertise, we aim to deliver an empathetic people-centric healthcare experience that helps people live longer.

Remio

Seed Round in 2022
Remio delivers a pre-configured VR headset to each team member and hosts the entire team for fun team-building experiences. Known as one of "the most fun ways to connect business teams", the VR HQ also offers collaboration tools such as whiteboarding, Jira project planning, and presentation rooms.

Turn.bio

Venture Round in 2022
Turn.bio is a biotechnology company developing drugs to reverse aging and age-related diseases. Utilizing a patented mRNA platform technology, ERA, the company is combating the effects of aging on the epigenome. The company’s proprietary mRNA platform technology, ERA and eTurna, a delivery platform specifically designed to enable nucleic acid therapeutics, combats the effects of aging in the epigenome, thus restoring optimal gene expression. It focuses on developing tailored therapies targeting indications in immune-related diseases like cancer and dermatological conditions, as well as therapies for ophthalmology, osteoarthritis, and the muscular system.

Leaft Foods

Series A in 2022
Leaft Foods exists to reduce the environmental impact of food production. We capture the most plentiful protein on the planet, Rubisco from green leaves.

HackerRank

Series D in 2022
HackerRank provides a platform that helps companies to evaluate technical skills and create opportunities. The company helps in hiring skilled developers by allowing tech recruiters and hiring managers to evaluate talent at every stage of the recruiting process.

World

Funding Round in 2022
World connects users through a privacy-focused network with secure digital asset management. The company is a privacy-focused human network incorporating a financial system to enhance global connectivity and trust. The World App allows users to securely store a World ID, manage digital assets, and easily access various Mini Apps.

Tarana Wireless

Venture Round in 2022
Tarana Wireless™ has pioneered a carrier-class universal wireless transport solution that is a breakthrough innovation with deterministic True NLOS performance, ubiquitous coverage, multi-kilometer range, industry-leading spectral efficiency, unprecedented capacity and scalability, zero-touch operation, and considerably lower total cost of ownership. It has the flexibility to be deployed for a wide range of applications including small cell backhaul, last mile fiber extension, tactical mobile operations, and more. Visit www.TaranaWireless.com for additional information.

Cor

Series A in 2022
COR helps you implement globally-proven healthy lifestyle practices, then shows you a totally new type of data about how your body responds. Optimize your lifestyle and discover the impact of different daily customs with precise, science-based self-knowledge.

Ava

Series A in 2022
Ava develops a live captioning platform that uses AI to transcribe what people say. It is committed to total accessibility for the 466M deaf/hh worldwide.

Hermeus

Series B in 2022
Hermeus is developing Mach 5 aircraft to speed up the global transportation network. Mach 5 flight is not just supersonic, it's hypersonic. At these speeds, a flight from New York to London is 90 minutes, rather than 7 hours. Its aircraft massively reduces flight times and increases safety for the long haul and business class air travel, enabling businesses to operate with minimal changes to current aviation infrastructure. The company was founded in 2018 and headquartered in Atlanta, Georgia.

Roofstock

Series E in 2022
Roofstock is an online marketplace for investing in leased single-family rental homes in a transparent and low-friction way. The company provides its clients with research, analytics, and insights to evaluate and purchase independently certified properties at set prices. It enables its investors to treat their real estate investments more like stock portfolios, focusing on asset allocation, rather than researching, and buying vacant homes that need to be repaired and leased. Founded in 2015, Roofstock gets its funding from Bain Capital, Ron Conway, Khosla Ventures, Marc Benioff, and other investment companies. It is headquartered in Oakland, California.

Volta Labs

Series A in 2022
Volta Labs is a biotechnology company that develops scalable automation for genetic engineering.

Aether Diamonds

Series A in 2022
Aether Diamonds produces the world's first and only diamonds made 100% from captured carbon. Certified B Corp. 2022 Fast Company Top 10 Most Innovative Consumer Goods Companies. 2022 "Best for the World" B Corp.

Emi Labs

Series A in 2022
At Emi we are on a mission to increase Frontline Workers’ access to professional opportunities. This is a population that accounts for +70% of the world’s workforce. They are digitally invisible, as there’s little to no data available on who they are, their career history, or their skill set, limiting their access to professional opportunities and growth. We're here to transform this by building the infrastructure to make Frontline Workers visible. Our first step to achieving our mission is to transform the recruiting experience into an easy, human and fair process, for both candidates and companies with high-volume job openings. Emi, our main product, is an A.I. recruitment assistant that enables companies to engage in a conversation with each applicant to detect interested and qualified individuals while saving Recruiters a huge amount of time by automating tasks such as screening, validating skills, scheduling interviews, and collecting documents. We operate with a remote-first culture with office hubs in Buenos Aires, Mexico City, and San Francisco.

Scipher Medicine

Series D in 2022
Scipher Medicine develops a healthcare platform designed to determine which drug will work best for each patient. The company is committed to transforming the way providers prescribe drugs, as well as the way manufacturers, develop new drugs. They are building a molecular map of all protein interactions that identifies genomic signatures and links those to disease and predictive treatment outcomes. Using a simple blood sample to analyze RNA, Scipher Medicine can predict if a patient is likely to respond to a targeted therapy before therapy is prescribed. This insight allows patients to start the most effective therapy from day one. For its first commercial product, they have developed PrismRA®, a first-of-its-kind blood test that can predict which patients with rheumatoid arthritis are less likely to respond to TNFi therapies such as Humira® and Enbrel® so that such patients can go on alternative approved drugs. Scipher Medicine is building the future of patient treatment. Most patients who are prescribed blockbuster therapies today don't respond to treatment, costing the healthcare industry billions in wasted drugs while patients continue to suffer. Scipher's platform identifies which drug will work based on the patient's fundamental disease biology, and not based on symptoms, disease classification, or medical bias. A routine blood test predicts which drug he/she will respond to, with our first product focusing on rheumatoid arthritis, ensuring that the most optimal treatment is prescribed from day one. The molecular data generated by our tests are then used to fuel novel target discovery to address a clear unmet medical need in patients who do not respond to any existing therapy.

WorkWhile

Series A in 2022
WorkWhile is an hourly labor technology platform that connects workers with shifts in various industries like warehouse, light industrial, last-mile delivery, hospitality, food production, and event services. It uses cognitive science and behavioral analysis to match workers to jobs that fit their skills, schedule, and location. The platform supports workers with perks like next-day pay and sick leave credits. WorkWhile was founded in 2017 by Amol Jain and Jarah Euston and is based in San Francisco, California.

Helium

Series D in 2022
Helium is an internet-of-things developer platform for building the network and transferring IoT device data. The platform builds the peer-to-peer wireless network to simplify connecting anything to the internet by rewarding anyone to become a network operator. It provides wireless coverage for low-power Internet of Things (IoT) devices and earns a new cryptocurrency, Helium, from your living room. Helium tokens by verifying network transactions, adding new blocks to the blockchain, and performing other tasks. The Proof-of-Coverage is a unique work algorithm that uses radio waves to validate that hotspots are providing legitimate wireless coverage.

Homebound

Series C in 2022
Homebound is a custom homebuilder that makes building the perfect home simple, transparent and human. Born out of the 2017 Northern California wildfires, Homebound was created by a local team of construction, real estate, design and technology experts who set out to create a better homebuilding solution for friends, family and neighbors affected. Homebound is the first homebuilder to manage the entire building process for homeowners and support them every step of the way — from insurance negotiation and architecture all the way to permitting, construction and move-in. Through easy-to-use technology and a network of vetted building experts, Homebound is simplifying the rebuilding process and alleviating the stress, complexity and uncertainty homeowners face after a natural disaster.

Verdagy

Series A in 2022
Verdagy is revolutionizing water electrolysis technology to facilitate large-scale green hydrogen production. Their solution achieves the lowest upfront capital costs and offers a competitive unit economics for production. Located in Moss Landing, California, Verdagy operates laboratory and pilot plant facilities to advance and rapidly scale its technology platform.

LEX Markets

Series A in 2022
LEX Markets is a commercial real estate securities marketplace that takes commercial buildings public through single-asset IPOs. It enables both accredited and non-accredited investors to buy and sell shares of individual commercial real estate assets without lockups, starting at $250. The company's platform is powered by Nasdaq to offer the same robust, low latency, and high-performance trading features used by 70+ global markets around the world. The company was founded in 2018 and is headquartered in New York.

Polly

Series B in 2022
The secondary market for mortgages accounts for over $1T in annual volume and impacts 20% of GDP. Yet, the pricing and loan trading of mortgages is still often done with antiquated technology, excel spreadsheets, phone calls, and physical paper. Billions of dollars are lost to inefficiency and mistakes. Polly is transforming the mortgage industry with its modern, data-driven capital markets ecosystem that includes an advanced Product & Pricing Engine (PPE), Loan Trading Exchange, Analytics Platform, and Partner Platform. Our mission is to help capital markets and secondary teams operate smarter, more efficiently, and more profitably with best-in-class, end-to-end technology that is configured for each of our customers’ unique workflows and business needs. Polly is based in San Francisco, California. Please visit www.polly.io to learn more.

Cellino

Series A in 2022
Cellino is building a scalable, automated biomanufacturing system for potentially curative personalized cell therapies. Cellino’s vision is to enable healthier lives worldwide with personalized treatments derived from induced pluripotent stem cells (iPSCs), which can serve as the basis for therapies for a host of chronic degenerative diseases, including vision loss and Parkinson's disease.

Lattice

Series F in 2022
Lattice is the People Success Platform that brings together all of the tools, workflows, and data needed to help business leaders develop engaged, high-performing employees and winning cultures. By combining continuous performance management, goal-setting, employee engagement, compensation management, career development, and people analytics into one unified solution, Lattice helps HR, People, and Operations teams develop insights that build enviable cultures and drive impactful business outcomes. Ranked on the Inc. 500 Fastest-Growing Private Companies list two years in a row and certified as a Great Place to Work by 99% of its employees, Lattice serves nearly 5,000 customers worldwide, including Slack, Asana, Solera Health, Guild Education, and the Los Angeles Dodgers. Learn more about Lattice by visiting: www.lattice.com. Ranked on the Inc. 500 Fastest-Growing Private Companies list two years in a row and certified as a Great Place to Work by 99% of its employees, Lattice serves nearly 5,000 customers worldwide, including Slack, Asana, Solera Health, Guild Education, and the Los Angeles Dodgers. Learn more about Lattice by visiting: www.lattice.com.

Faeth Therapeutics

Seed Round in 2022
Faeth Therapeutics is a data-driven, evidence-based company that specializes in mechanistic understanding of the way that dietary nutrients influence tumor growth and cancer treatment. It fully focuses on matching specific diets with tumor genotypes and treatment regimens to improve the outcomes of cancer therapy. The company was founded to translate breakthrough discoveries, made by cancer research laboratories, into clinical practice. Its founding team includes some of the industry’s preeminent researchers and clinicians.

Seashell

Seed Round in 2022
Seashell is reimagining the flow of money. As a compliance-focused financial product, Seashell provides the simplest way to earn high and stable interest. Seashell's technology harnesses blockchain innovations to offer market-leading and compliant yields at the push of a button, putting more money into everyone's pocket.

Azibo

Series A in 2022
Azibo is a financial services platform for rental properties that provides solutions for rent collection, banking, lending, and insurance. The company was founded in 2018 and is headquartered in Reno, Nevada.

Anagenex

Seed Round in 2022
Anagenex is a seed stage biotechnology company building a novel platform for drug discovery focusing on difficult targets.

GoodTrust

Seed Round in 2021
GoodTrust is on a mission to protect everyone's digital life and legacy with Smart Online Estate Planning. Today 77% of all US adults say they want a Will, but only 33% have it today. With GoodTrust anyone can now create their Will- or Trust-based estate plan including all their important Directives and linked Smart Digital Vault for your accounts, documents, photos, and devices. Fast, easy, and secure with legal documents in all 50 states. GoodTrust has a ready to go solution with no IT-integration, that we can launch within days if you want.

Draft

Venture Round in 2021
Draft leverages the recent advances in blockchain technology to build job marketplace platform from the ground up.

NextVivo

Seed Round in 2021
NextVivo is a biotech company developing an immune organoid technology platform to transform the future of drug development. Its mission is to accelerate the development of safer, more effective therapies that are generated and tested in immune-competent human-derived models.

Robin Healthcare

Series B in 2021
Robin Healthcare provides medical scribe services. They help remove barriers to health and improve the doctor-patient experience. They offer technology and trained medical scribes to deliver a seamless experience that integrates directly into the electronic medical record, taking on the administrative burdens of medicine so doctors can reclaim their time and maintain control over their practice.

Nabla Bio

Seed Round in 2021
Nabla is an autoreverse platform that enables the rapid discovery of previously unattainable protein variants with supernatural qualities. Nabla Bio makes new medicines and improve nutrition by engineering novel proteins.

Fundbox

Series D in 2021
Fundbox is an AI-powered financial platform for small businesses that offer fast and intuitive access to business credit. The company is on a mission to empower the small business economy by unlocking customer growth. It is headquartered in San Francisco, California by co-founders Eyal Shinar, Tomer Michaeli, and Yuval Ariav in 2013.

CloudTrucks

Series B in 2021
CloudTrucks develops a virtual trucking carrier application designed to reduce operating costs for truck drivers. The platform helps to manage and book loads from brokers and shippers, offer instant payments after load delivery, and access to cheap insurance options, enabling truck owners and operators to strategize their schedule and design a revenue-maximizing driving program. The company was founded in 2019 and is headquartered in San Francisco, California.

Simplified

Seed Round in 2021
Simplified is an all-in-one, AI-powered app to help teams and businesses with content creation and marketing. You can design, create videos, write copy and manage social media without switching tabs. With Simplified, you can streamline your content creation process and increase productivity by utilizing its AI-powered tools for creating engaging and high-quality content. This app offers a wide range of features, including a video editor, graphic design tools, and a social media scheduler. Moreover, Simplified provides you with ready-made templates that you can customize as per your requirements. These templates ensure your content is consistent and on-brand.

Lessen

Series B in 2021
Lessen is a technologically enabled, end-to-end solution for outsourced real-estate property services that delivers consistency, quality, and speed at scale. This includes primarily single-family and multifamily rental renovations, turns, and maintenance. Through automation and real-time analytics, the company's technology suite is disrupting and modernizing a project management space that is still reliant on traditional organizational and communication models. Using its proprietary technology platform, its professional field project managers provide hands-on service and leverage a network of vetted service professionals in over 40 markets across the country.

Sword Health

Series D in 2021
Sword Health is on a mission to free 2 billion people from pain by pioneering the field of AI Care. It is #1 in clinical and cost-saving outcomes because we have the most advanced AI, developed and overseen by the most clinically rigorous team. Sword has developed the first platform to predict, prevent, and treat pain by starting with the expertise of world-class doctors of physical therapy and then building an interactive AI experience to deliver care that members can use anywhere, anytime, under a clinician’s supervision.

Up&Up

Series B in 2021
Up&Up is a platform that enables fractional homeownership. It aims to provide a more accessible, flexible, and rewarding way to rent and own a home. It helps in building a nest egg for whenever the buyer is ready to buy or cash out by making every resident a part-owner in the home of their choice. It’s a flexible, forward-thinking alternative to the traditional rental model that enriches the future. It was founded in 2017 and is headquartered in New York, New York.

Fountain Therapeutics

Series A in 2021
Fountain Therapeutics is discovering and developing treatments for aging-associated diseases. Fountain Therapeutics was founded with the belief that a future in which we live healthier lives longer is more desirable than one in which the company continues to be afflicted by the disease of aging. The company builds a transformative model of aging that re-creates many of the complex hallmark features of aging but in a laboratory dish. We are combining this powerful cellular model with the latest in artificial intelligence and computer vision to develop a disruptive unbiased platform for the identification of novel targets and potential therapeutics.

OpenStore

Series B in 2021
OpenStore connects merchants and customers into a single unified shopping experience through access to data, information, and capital. The company aims to offer instant liquidity for eCommerce entrepreneurs.

Daedalus

Seed Round in 2021
Daedalus is building the world’s most advanced factories for precision components. With $40M in funding from Khosla Ventures, Addition, NGP Capital and Y Combinator, and a team from OpenAI, Google, SpaceX and Blue Horizon, we’re building software-defined factories where we’re producing parts for companies in semiconductor, aerospace, medical, energy, defense and more.

Heyday

Series C in 2021
Heyday is a consumer-focused business that operates an online platform for brands in digital marketplaces, helping them enhance their eCommerce presence. Founded in 2020 and based in San Francisco, the company aims to support sellers in reaching new heights within the marketplace landscape. Additionally, Heyday Wellness, established in 2015 and located in New York, specializes in customized skincare services, offering tailored facial treatments that include deep cleansing, skin analysis, exfoliation, extractions, hydration, and SPF protection. The wellness segment also features a range of skincare products such as beauty creams, lotions, and wipes available through both physical stores and online channels. Together, these offerings position Heyday as a versatile player in the beauty and skincare industry.

Faire

Series G in 2021
Faire is a two-sided marketplace and wholesale platform that helps retailers find and buy unique wholesale merchandise for their stores while helping brands and makers reach local retailers. Faire offers business owners a toolkit of simple tech, data insights, financial terms, and logistics solutions to support the future of local retail. Faire's net 60 payment terms and free returns take the risk out of the wholesale business so that local retailers and independent brands can compete with big-box and ecommerce giants. Faire is headquartered in San Francisco, California, United States, and Kitchener, Ontario, Canada.

ThoughtSpot

Series F in 2021
ThoughtSpot is the AI-native Intelligence Platform for every enterprise. Our mission is to create a more fact-driven world by empowering everyone to explore any data, ask any question, and uncover actionable insights faster—leading to growth, better business outcomes, and efficiency in their organizations. With ThoughtSpot’s intuitive natural language search, every user can confidently generate answers from their business data at every point of decisioning. The platform’s unified capabilities, along with our agentic AI analyst, Spotter, enable users to create precise, transparent, personalized, and actionable insights with enterprise grade trust, security, and scale. Accessible via the web and mobile app, ThoughtSpot ensures intelligent decision-making happens seamlessly, wherever and whenever needed. For developers, ThoughtSpot Embedded offers a low-code solution to integrate AI-powered analytics directly into products and services, driving data monetization and boosting user engagement for customers. Industry leaders like NVIDIA, Hilton Worldwide, Capital One and Huel rely on ThoughtSpot to transform how their employees and customers take advantage of data to create better business outcomes. Try ThoughtSpot today and experience the new era of analytics. The company was co-founded in 2012 by its CEO Ajeet Singh and six other technical co-founders from Google, Microsoft, Amazon, and Oracle. It is based in Palo Alto, CA, and is currently expanding operations in North America, Europe, and Asia-Pacific.

Mimica

Seed Round in 2021
Bump by Mimica is a patented label or cap that turns bumpy when food or drinks should no longer be consumed, based on actual temperature conditions. It provides accurate, real-time indication of the product’s freshness with a tactile interface. This time and temperature response is calibrated to different food types to suit food suppliers' requirements. Globally, a third of food produced is wasted (FAO, 2015), with 60% of it still being safe for consumption. Mimica is creating the next generation of food expiry labelling that reduces food waste and improves safety. We project, based on previous research, that using Bump by Mimica will reduce retail food waste by 50% and home waste by 60%. Based on these estimates and consumption data verified by Mintel and WRAP, we expect Mimica to save up to 13.6 million tonnes of our first three food groups (juice, milk and meat) from landfill per year in European households alone. Mimica is paving the way for a more efficient, less wasteful food system.

Mimica Automation

Series A in 2021
Mimica watches you work and learns to automate your most repetitive tasks. Its research and tech are backed by Entrepreneur First, Europe's most successful accelerator and seed fund.

Viome

Series C in 2021
Viome, Inc. is a biotechnology company based in Bellevue, Washington, that specializes in wellness monitoring through at-home clinical-grade testing kits. Founded in 2016, the company combines analyses of blood, urine, saliva, and stool samples to create detailed profiles of an individual's biochemistry and gut microbiome. Utilizing proprietary RNA sequencing technology, Viome assesses the microbial communities in the digestive system and provides users with personalized insights related to their health. The findings are integrated into a smartphone application that offers tailored recommendations for diet and lifestyle adjustments aimed at preventing and reversing chronic diseases. Viome markets its products through various distributors and online platforms, operating as a subsidiary of BlueDot LLC.

Because Market

Series B in 2021
Because is a high growth, direct-to-consumer personal care company focused on older adults. We started in 2017 with a simple idea - to make it easier for our families to get the products they needed. Today, we are on our way to becoming the #1 trusted brand for older adults, with the goal of helping millions lead vibrant, independent lives. We’ve raised over $40M in funding from top VC firms including Index Ventures and Khosla Ventures, and are grateful for the support for our customers, partners and investors.

Splash

Series A in 2021
Splash develops AI-powered video games that lets anyone create and perform music to live audiences inside virtual venues.

Vertical Oceans

Seed Round in 2021
Vertical Oceans produces same day farm to fork shrimp is vertical aqua towers in major urban markets. Our system uses no chemicals or antibiotics and produces no effluent. Our system includes 83 technologies across bioengineering, hardware engineering and computational engineering. Our technology starts with a biocomputer we call the Intelligent Habitat, or iHAB. It is a self-sustaining, self-cleaning modular production system. Inside the iHAB we have a unique aquatic ecosystem which uses fish and seaweed as part of the biofiltration and creates a more natural environment. The result is a great tasting shrimp with excellent sustainability credentials.

Supplant

Series A in 2021
Supplant is a biotechnology platform working in the food sector. It develops natural food ingredients from agricultural resources to allow food manufacturers to decrease sugar, increase fiber, and boost the gut health-promoting qualities of its products.

Lightship

Series C in 2021
We believe clinical research can be built to improve health equity globally. Learning if treatments are safe and effective for the people who need them requires us to offer studies that are more accessible and offer choice. We founded Lightship in 2018 with the inspiration to keep people at the heart of our work and use the latest innovations in digital health, technology, and remote care melded with high quality clinical research to transform clinical trials.

Enso

Seed Round in 2021
Enso is a creative impact agency based in Santa Monica, California, founded in 2012. The agency focuses on leveraging strategic, creative, and community-building skills to improve both the planet and the lives of individuals. Enso aims to disrupt the status quo by developing innovative ideas that can scale through shared missions, fostering collaboration among brands, organizations, and communities around common goals. Additionally, Enso facilitates the rapid creation of software, enabling business leaders, analysts, data scientists, and developers to design workflows collaboratively and enhance communication effectively.

All Day Kitchens

Series C in 2021
All Day Kitchens focuses on building delivery-optimized kitchens. Its delivery-optimized kitchens and technology unlock delivery coverage with minimal upfront investment.

Velo3D

Post in 2021
Velo3D is a digital manufacturing company using a Sapphire 3D production printer and flow print preparation software to print 3D metals. Bringing together an integrated solution of software, hardware, and process-control innovation, Velo3D introduced the first SupportFree capability for 3D metal printing. This enables unlimited design innovation by reducing the need for support structures in metal additive manufacturing. The company’s Sapphire system is built with a semiconductor mindset on quality assurance, ensuring repeatability and dependability throughout serial manufacturing.

Loop

Series A in 2021
By using data, technology, and high quality medical expertise, we aim to deliver an empathetic people-centric healthcare experience that helps people live longer.

Breeze

Seed Round in 2021
Breeze is a fully automated and digital insurance solution, specifically tailored for freight forwarders and logistics companies, backed by advanced technology, big data and an industry-first machine learning platform. Breeze’s digital insurance solution fully integrates with existing systems and workflows, allowing forwarders and logistics companies to seamlessly offer shippers better protection for their cargo (from issuing insurance policies to end-to-end claims processing), while also generating more revenue for their business. There are no implementation costs or any operational effort to setting up Breeze’s platform, and it can take minutes to be up and running. For more information visit breezeai.com

VitroLabs

Series A in 2021
VitroLabs is a startup working on the cutting edge of 3D tissue engineering using stem cell-based technologies. The company develops a fully scalable tissue engineering platform combining the latest breakthroughs in stem cell research and biomaterials. It manufactures real leather without the need to raise and slaughter animals using breakthroughs in stem cell research and tissue engineering. VitroLabs was founded on 2016 and is based in San Jose, California.

Loyal

Series A in 2021
Loyal is a biotechnology company developing medicines to extend dog lifespan. By developing drugs with the potential to slow the aging process, they aim to delay or prevent age-related diseases like cancer and dementia. By quantifying and regulating the processes of aging, the company aims to slow the emergence and mitigate the intensity of age-related ailments, thereby facilitating extended periods of improved health for both species.

Opentrons

Series C in 2021
Opentrons is a developer of pipetting robot technology designed to automate experiments. Their technology is automated laboratory equipment that automates experiments by using the Python language, enabling scientific researchers to make the process faster and less tiresome.

Vicarious Surgical

Post in 2021
Vicarious Surgical is a next-generation robotics company developing a disruptive technology with the goal of increasing the efficiency of surgical procedures, improving patient outcomes and reducing healthcare costs. Vicarious Surgical aims to revolutionize the field of minimally invasive surgery by developing advanced robotic systems that allow surgeons to perform complex procedures with greater precision and control. The company's robotic system is designed to be compact and portable, enabling it to be easily integrated into existing operating rooms without significant modifications. The robot's design also aims to minimize the invasiveness of surgical procedures, leading to faster patient recovery times and reduced post-operative discomfort.

Vahan.ai

Series A in 2021
Vanan Online Services provides Translation,Transcription, Captioning and Subtitling,Voice Over, Typing on a single platform.

Statespace

Series C in 2021
StateSpace provides performance analytics and a suite of tools for casual gamers and esports athletes to maximize their potential. It uses cognitive science and artificial intelligence to revolutionize the way humans improve. Leveraging expertise as neuroscientists, data scientists, video game developers, and computer visionaries, the products bring much needed standardized performance analytics to train.It was founded in 2017 and is headquartered in New York, New York.

Juno

Series A in 2021
Juno Residential develops apartment buildings intended to offer environment-friendly and speedy housing alternatives. It uses prefabrication techniques and organic and low-carbon materials like mass timber, thereby providing clients with modern and curated apartments.

PolyAI

Series A in 2021
PolyAI develops a machine learning platform for conversational artificial intelligence. PolyAI builds enterprise voice assistants that carry on natural conversations with customers to solve their problems. PolyAI's voice assistants understand customers, regardless of what they say or how they say it. Founded in 2017, the company has its headquarters in London, England, United Kingdom, and New York, United States of America.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.